InvestSMART

Genera Biosystems Limited (ASX: GBI) - Announcements

DELISTED - Current share price for GBI : $0.160

ASX company news and announcements for Genera Biosystems Limited (GBI) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Genera Biosystems Limited (GBI) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Genera Biosystems Limited (GBI), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Genera Biosystems Limited (GBI)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
- Preliminary Final Report 30 Aug 2013 12:55PM $0.070 $0.160 risen by 128.57%
- Response to ASX Query - Appendix 4C 13 Aug 2013 8:49AM $0.100 $0.160 risen by 60%
- Appendix 4C - quarterly 31 Jul 2013 11:24AM $0.100 $0.160 risen by 60%
- Capital Raising and Business Update 17 Jul 2013 9:29AM $0.105 $0.160 risen by 52.38%
- Reinstatement to Official Quotation 17 Jul 2013 9:29AM $0.105 $0.160 risen by 52.38%
- Suspension from Official Quotation 10 Jul 2013 10:17AM $0.105 $0.160 risen by 52.38%
- Trading Halt 8 Jul 2013 9:53AM $0.105 $0.160 risen by 52.38%
- Business Update 1 May 2013 9:13AM $0.075 $0.160 risen by 113.33%
- Appendix 4C - quarterly 30 Apr 2013 9:41AM $0.070 $0.160 risen by 128.57%
- Appendix 4D and Half Year Financial Report 28 Feb 2013 12:16PM $0.090 $0.160 risen by 77.78%
- Appendix 4C - quarterly & Business Update 31 Jan 2013 12:11PM $0.125 $0.160 risen by 28%
- Share Placement, Company Secretary change 18 Dec 2012 3:01PM $0.115 $0.160 risen by 39.13%
- AGM - Chairman's Address to Shareholders 22 Nov 2012 11:17AM $0.150 $0.160 risen by 6.67%
- Appendix 4C - quarterly & Business Update 30 Oct 2012 9:37AM $0.160 $0.160 fallen by 0%
- Preliminary Final Report 28 Aug 2012 5:05PM $0.180 $0.160 fallen by 11.11%
- Appendix 4C - quarterly & Business Update 31 Jul 2012 12:24PM $0.175 $0.160 fallen by 8.57%
- Commercial Evaluation Agreement with Brazilian Path Lab 6 Jun 2012 12:34PM $0.210 $0.160 fallen by 23.81%
- Business Update and Share Purchase Plan extension 25 May 2012 12:23PM $0.210 $0.160 fallen by 23.81%
- Appendix 4C - quarterly, Share Purchase Plan announced 30 Apr 2012 3:22PM $0.230 $0.160 fallen by 30.43%
- Trading Halt 30 Apr 2012 9:12AM $0.235 $0.160 fallen by 31.91%
- Genera Biosystems Business Update 24 Apr 2012 10:01AM $0.240 $0.160 fallen by 33.33%
- Half Yearly Report and Accounts 27 Feb 2012 6:19PM $0.180 $0.160 fallen by 11.11%
- Appendix 4C - quarterly and Business Update 31 Jan 2012 3:24PM $0.160 $0.160 fallen by 0%
- Conclusion of PapType UK clinical study 2 Nov 2011 1:52PM $0.145 $0.160 risen by 10.34%
- Appendix 4C - quarterly 27 Oct 2011 4:59PM $0.145 $0.160 risen by 10.34%

201 - 225 of 275 results

Page 9 of 11

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.